Literature DB >> 19192035

Disorders from perturbations of nuclear-mitochondrial intergenomic cross-talk.

A Spinazzola1, M Zeviani.   

Abstract

In the course of evolution, mitochondria lost their independence, and mitochondrial DNA (mtDNA) became the 'slave' of nuclear DNA, depending on numerous nucleus-encoded factors for its integrity, replication and expression. Mutations in any of these factors may alter the cross-talk between the two genomes and cause Mendelian disorders characterized by qualitative (multiple deletions) or quantitative (depletion) alterations of mtDNA, or by defective translation of mtDNA-encoded respiratory chain components.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19192035     DOI: 10.1111/j.1365-2796.2008.02059.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  20 in total

1.  OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution.

Authors:  Ghizlane Elachouri; Sara Vidoni; Claudia Zanna; Alexandre Pattyn; Hassan Boukhaddaoui; Karen Gaget; Patrick Yu-Wai-Man; Giuseppe Gasparre; Emmanuelle Sarzi; Cécile Delettre; Aurélien Olichon; Dominique Loiseau; Pascal Reynier; Patrick F Chinnery; Agnès Rotig; Valerio Carelli; Christian P Hamel; Michela Rugolo; Guy Lenaers
Journal:  Genome Res       Date:  2010-10-25       Impact factor: 9.043

Review 2.  Alpers-Huttenlocher syndrome.

Authors:  Russell P Saneto; Bruce H Cohen; William C Copeland; Robert K Naviaux
Journal:  Pediatr Neurol       Date:  2013-03       Impact factor: 3.372

3.  Impairment of mitochondrial tRNAIle processing by a novel mutation associated with chronic progressive external ophthalmoplegia.

Authors:  A Schaller; R Desetty; D Hahn; C B Jackson; J-M Nuoffer; S Gallati; L Levinger
Journal:  Mitochondrion       Date:  2011-02-01       Impact factor: 4.160

Review 4.  Therapeutic prospects for mitochondrial disease.

Authors:  Eric A Schon; Salvatore DiMauro; Michio Hirano; Robert W Gilkerson
Journal:  Trends Mol Med       Date:  2010-06       Impact factor: 11.951

5.  An altered peripheral IL6 response in major depressive disorder.

Authors:  Kelli M Money; Zita Olah; Zeljka Korade; Krassimira A Garbett; Richard C Shelton; Karoly Mirnics
Journal:  Neurobiol Dis       Date:  2016-01-22       Impact factor: 5.996

6.  Impairment of mitochondrial-nuclear cross talk in neutrophils of patients with type 2 diabetes mellitus.

Authors:  Saba Khan; Gorantla V Raghuram; Neelam Pathak; Subodh K Jain; Dolly H Chandra; Pradyumna K Mishra
Journal:  Indian J Clin Biochem       Date:  2013-04-02

7.  Antenatal manifestations of mitochondrial disorders.

Authors:  Mariana Vide Tavares; Maria João Santos; Ana Patrícia Domingues; João Pratas; Cândida Mendes; Marta Simões; Paulo Moura; Luísa Diogo; Manuela Grazina
Journal:  J Inherit Metab Dis       Date:  2013-01-30       Impact factor: 4.982

8.  Functional consequences of mitochondrial tRNA Trp and tRNA Arg mutations causing combined OXPHOS defects.

Authors:  Paulien Smits; Sandy Mattijssen; Eva Morava; Mariël van den Brand; Frans van den Brandt; Frits Wijburg; Ger Pruijn; Jan Smeitink; Leo Nijtmans; Richard Rodenburg; Lambert van den Heuvel
Journal:  Eur J Hum Genet       Date:  2009-10-07       Impact factor: 4.246

9.  The clinical spectrum and natural history of early-onset diseases due to DNA polymerase gamma mutations.

Authors:  Omar Hikmat; Charalampos Tzoulis; Wui K Chong; Latifa Chentouf; Claus Klingenberg; Carl Fratter; Lucinda J Carr; Prab Prabhakar; Nandhini Kumaraguru; Paul Gissen; J Helen Cross; Thomas S Jacques; Jan-Willem Taanman; Laurence A Bindoff; Shamima Rahman
Journal:  Genet Med       Date:  2017-04-27       Impact factor: 8.822

10.  A novel homozygous mutation in SUCLA2 gene identified by exome sequencing.

Authors:  Costanza Lamperti; Mingyan Fang; Federica Invernizzi; Xuanzhu Liu; Hairong Wang; Qing Zhang; Franco Carrara; Isabella Moroni; Massimo Zeviani; Jianguo Zhang; Daniele Ghezzi
Journal:  Mol Genet Metab       Date:  2012-09-07       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.